Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation
about
Mucin-Type O-Glycosylation in Gastric CarcinogenesisN-acetylgalactosaminyltransferases in cancer.Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling.An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides.GalNAc-T15 in gastric adenocarcinoma: Characterization according to tissue architecture and cellular location.The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities
P2860
Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mucin glycosylating enzyme GAL ...... y reducing MET phosphorylation
@en
type
label
Mucin glycosylating enzyme GAL ...... y reducing MET phosphorylation
@en
prefLabel
Mucin glycosylating enzyme GAL ...... y reducing MET phosphorylation
@en
P2093
P2860
P50
P356
P1433
P1476
Mucin glycosylating enzyme GAL ...... y reducing MET phosphorylation
@en
P2093
Chia-Lang Hsu
Chia-Tung Shun
Shin-Yun Liu
P2860
P304
11251-11262
P356
10.18632/ONCOTARGET.7081
P407
P577
2016-01-30T00:00:00Z